Rani Therapeutics Holdings, Inc. (RANI)
Rani Therapeutics Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Rani Therapeutics Holdings, Inc. (RANI) is a Biotechnology company based in US with a market capitalization of $45.1M. Free cash flow was negative at -$18.8M. This page tracks RANI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 105 employees · IPO Jul 30, 2021
Valuation
Valuation & price
$1.08as of May 17, 2026· -62.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.37
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$45.1M
Market cap
—
Revenue growth (YoY)
44.9%
Gross margin
-$18.8M
Free cash flow (USD)
-$45.4M
Net debt
Net cash position
132.3%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2019 → 2025
Free cash flow by year
2019 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
2
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.04)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- Insider buyJul 23, 2026Filing
Insider Buy $25KIMRAN MIR A · Director, 10% Owner · $24.8K
- Insider sellJul 21, 2026Filing
Insider Sell $301Javadi Alireza · Chief Technical Officer · $301.1
- Insider sellJul 21, 2026Filing
Insider Sell $11KImran Talat · Director, Chief Executive Officer · $11.3K
- Insider buyJul 21, 2026Filing
Insider Buy $25KImran Talat · Director, Chief Executive Officer · $25.2K
- 8-K eventJun 29, 2026Filing
Equity Inducement Plan Adopted
- 8-K eventMay 29, 2026Filing
Annual Meeting Results
- 8-K eventMay 27, 2026Filing
Securities Purchase Agreement
- 8-K eventMay 15, 2026Filing
CFO Transition
- Quarterly reportMay 15, 2026Filing
10-Q Filed
Questions
Frequently asked questions
What is Rani Therapeutics Holdings, Inc.'s market cap?
Rani Therapeutics Holdings, Inc. (RANI) has a market capitalization of $45.1M.
What is RANI's P/E ratio?
A meaningful P/E ratio is not available for RANI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is RANI's price-to-book (P/B) ratio?
RANI trades at 1.37 times book value per share.
When did Rani Therapeutics Holdings, Inc. last report earnings?
RANI last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying RANI stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 2 sells at Rani Therapeutics Holdings, Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.